Completed PHASE3 INTERVENTIONAL 2-arm
NCT07344922
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia
Impact of Sodium-Glucose Co-transporter 2 Inhibitors on Cardiovascular System and Anemia in Non-diabetic Chronic Kidney Disease Patients. A Randomized-Controlled Clinical Trial
Sponsor: Mansoura University
Updated 1 time since 2026 Last updated: Jan 8, 2026 Started: Sep 1, 2022 Primary completion: Nov 1, 2023 Completion: Dec 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Anemia and Cardiovascular Calcification, this trial is completed. The trial is conducted by Mansoura University and has accumulated 1 data snapshot since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
1 version recorded Completed — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mansoura University
Data source: Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .